Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / point biopharma global pnt news johnson fistel inves mwn benzinga

PNT - POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price? | Benzinga

POINT Biopharma Global Inc.

  • SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma Global, Inc. ("POINT") (NASDAQ:PNT) breached their fiduciary duties in connection with the proposed sale of the Company to Eli Lilly and Company.

    On October 3, 2023, POINT announced that it had entered a deal with Eli Lilly and Company. Under the terms of this agreement, shareholders will receive $12.50 per share in an all-cash offer.

    The investigation concerns whether the POINT board failed ...

    PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price?>Full story available on Benzinga.com

    •
    Stock Information
    Company Name: POINT Biopharma Global Inc.
    Stock Symbol: PNT
    Market: NASDAQ
    Menu
    PNT PNT Quote PNT Short PNT News PNT Articles PNT Message Board
    Get PNT Alerts

    News, Short Squeeze, Breakout and More Instantly...